DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 103 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2017. The put-call ratio across all filers is 0.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,721,000 | +778.1% | 89,609 | +97.2% | 0.03% | +211.1% |
| Q3 2020 | $196,000 | +2.1% | 45,448 | +342.5% | 0.01% | +80.0% |
| Q4 2017 | $192,000 | -23.5% | 10,271 | -83.9% | 0.01% | -16.7% |
| Q4 2016 | $251,000 | +5.5% | 63,600 | +180.7% | 0.01% | 0.0% |
| Q3 2016 | $238,000 | -66.3% | 22,654 | -38.3% | 0.01% | -66.7% |
| Q1 2016 | $706,000 | +0.7% | 36,699 | +26.6% | 0.02% | -10.0% |
| Q4 2015 | $701,000 | -3.0% | 28,997 | -1.5% | 0.02% | -16.7% |
| Q3 2015 | $723,000 | – | 29,443 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |